EDAP
Edap Tms S.a.
Set alert
- YTD
- +44.53%
- 1 year
- +168.64%
- Open
- 4.75
- Prev close
- 4.76
- Mkt cap
- 82.37M
- Vol
- 28.86K
- Avg vol
- 161.81K
- EPS
- -0.62
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.50
- High
- 4.80
- Forward P/E
- -4.72
- Beta
- 0.38
- Short ratio
- 0.22
- Inst. own
- 42.45%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.53
- 200-d avg
- 4.66
- 1y target
- 10.67
Discussion (28)
Sign in to join the discussion
$EDAP lessss go
$EDAP lesss goooo
$EDAP should run sooner or later, way undervalued
- Potential Connection:
Given Biden's diagnosis, he and his family are likely exploring various treatment options with his physicians.
HIFU, and specifically EDAP TMS's Focal One, could be one of the treatment options considered, particularly if the cancer remains localized.
However, it's important to note that HIFU is not a first-line treatment for aggressive prostate cancer that has metastasized.
HIFU might be an option for treating recurrent prostate cancer after radiation therapy or for localized tumors, but Biden's case involves bone metastasis.
$EDAP 3. Potential Connection:
Given Biden's diagnosis, he and his family are likely exploring various treatment options with his physicians.
HIFU, and specifically EDAP TMS's Focal One, could be one of the treatment options considered, particularly if the cancer remains localized.
However, it's important to note that HIFU is not a first-line treatment for aggressive prostate cancer that has metastasized.
HIFU might be an option for treating recurrent prostate cancer after radiation therapy or for localized tumors, but Biden's case involves bone metastasis.
- Potential Connection:
Given Biden's diagnosis, he and his family are likely exploring various treatment options with his physicians.
HIFU, and specifically EDAP TMS's Focal One, could be one of the treatment options considered, particularly if the cancer remains localized.
However, it's important to note that HIFU is not a first-line treatment for aggressive prostate cancer that has metastasized.
HIFU might be an option for treating recurrent prostate cancer after radiation therapy or for localized tumors, but Biden's case involves bone metastasis.
Will Biden prostate cancer give more awareness to EDAP
$EDAP Hold on to your shares guys!
$EDAP On March 26, 2025, the Company’s Focal One Robotic HIFU System received CE Mark certification from GMED, EDAP’s notified body, for the treatment of posterior deep endometriosis infiltrating the rectum and surrounding structures.
Do the math, see below:
Deep infiltrating endometriosis (DIE), a severe form of endometriosis, affects around 10-20% of all endometriosis cases, infiltrating organs near the pelvic cavity, and is characterized by pain, infertility, and potential bowel or urinary issues
Endometriosis affects roughly 10% of reproductive-age women globally, with an estimated 190 million people affected worldwide, and it can cause severe pain, infertility, and other health issues
$EDAP Beautiful news! I told you don’t follow Mike the scammer